Asia-Pacific Knee Cartilage Repair Market - Industry Trends and Forecast to 2030
Asia-Pacific Knee Cartilage Repair Market, By Product (Cell-Based & Non-Cell Based), Modality (Osteochondral Transplantation, Microfracture, Abrasion Arthroplasty, Drilling, Chondrocyte Implantation, and Others), Cartilage Type (Hyaline Cartilage, and Fibrocartilage), Application (Osteoarthritis, Rheumatoid Arthritis, Osteonecrosis, Fractures, Bone Tumors, and Others), End User (Hospital, Ambulatory Surgical Centers, Specialty Clinics, Research and Academic Institutes, and Others), Distribution Channel (Direct Sale, Third Party Distributor, Online Sales, and Others), Country (Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, and Rest of Asia-Pacific) Industry Trends and Forecast to 2030
Market Definition:
The knee is the largest joint in the body. The upper and lower bones of the knee are separated by two discs (menisci). The upper leg bone (femur) and the lower leg bones (tibia and fibula) are connected by ligaments and tendons. Cartilage is the most common type of connective tissue. It is found in various forms throughout our joints, spine, bones, ears, lungs, and nose. Cartilage is a flexible connective tissue that coats the surfaces of the bones in our joints and protects them against impact to maintain joint mobility fluid.
Knee cartilage repair is a procedure that involves repairing damaged cartilage while also smoothing the tissue's remaining surface. Cartilage repair surgery, which attempts to restore cartilage tissue and function to avoid long-term osteoarthritis, is an appropriate treatment choice for focal full-thickness cartilage abnormalities in the knee. Osteotomy, knee replacement, and microfracture are some of the most common knee cartilage repair techniques. The surgical techniques or less prevalent surgical procedures, such as allograft osteochondral transplantation, autologous chondrocyte implantation, and artificial scaffolds, are sometimes utilized to repair cartilage injury.
Market Segmentation:
The Asia-Pacific knee cartilage market is categorized into six notable segments based on product, modality, cartilage type, application, end user, and distribution channel.
• On the basis of product, the Asia-Pacific knee cartilage repair market is segmented into cell-based and non-cell-based
• On the basis of modality, the Asia-Pacific knee cartilage repair market is segmented into osteochondral transplantation, microfracture, drilling, chondrocyte implantation, abrasion arthroplasty, and others
• On the basis of cartilage type, the Asia-Pacific knee cartilage repair market is segmented into hyaline cartilage and fibrocartilage
• On the basis of application, the Asia-Pacific knee cartilage repair market is segmented into osteoarthritis, rheumatoid arthritis, osteonecrosis, fractures, bone tumors, and others
• On the basis of end user, the Asia-Pacific knee cartilage repair market is segmented into hospital, ambulatory surgical centers, specialty clinics, research and academic institutes, and others
• On the basis of distribution channel, the Asia-Pacific knee cartilage repair market is segmented into direct sales, third party distributor, online sales, and others
Market Players
Some of the major players operating in the Asia-Pacific knee cartilage repair market are:
• Stryker
• Zimmer Biomet
• B. Braun Melsungen AG
• Smith & Nephew
• BioTissue
• CONMED
• DePuy Synthes Companies
• Arthrex, Inc.
• Medacta International
• Regrow Biosciences Pvt. Ltd
• Regentis Biomaterials Ltd.
• Anika Therapeutics, Inc.
• Auxein Medical
• BioGend Therapeutics Co., Ltd.
• CartiHeal, Inc. (A subsidiary of Bioventus Inc.)
• MEDIPOST
• Sartorius CellGenix GmbH
• Sanofi
• Waldemar Link GmbH & Co. KG
• Geistlich Pharma AG
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook